Sanofi sticks to $69 per share Genzyme offer

2010-09-09T07:00:09Z

PARIS (Reuters) - French drugmaker Sanofi-Aventis poured cold water on reports it had raised its offer for Genzyme , saying it was sticking to its bid of $18.5 billion, or $69 per share. "There is one offer, at $69 a share," spokeman

Emergent's Trubion buyout clears regulatory hurdle

2010-09-08T16:02:04Z

Emergent BioSolutions purchase of Trubion Pharma clears regulatory hurdle early

The planned buyout of Trubion Pharmaceuticals Inc. by Emergent BioSolutions Inc. cleared a regulatory hurdle Wednesday, bringing the deal, potentially worth $135.5 million, closer to closing. The Department of ...

Sanofi pitched $71 offer to Genzyme: report

2010-09-08T09:30:51Z

BOSTON (Reuters) - Sanofi-Aventis SA pitched a new offer to acquire U.S. biotechnology company Genzyme Corp for $71 a share in exchange for the opportunity to conduct "partial due diligence," according to DealReporter, which cited a...

Bristol-Myers agrees to buy ZymoGenetics for $885M

2010-09-07T14:50:06Z

Bristol-Myers Squibb says it will buy ZymoGenetics for $885M, or $9.75 per share in cash

Bristol-Myers Squibb Co. says it will acquire biotechnology company ZymoGenetics Inc. for $885 million, or $9.75 per share. The New York drugmaker says its bid is worth $735 million excluding ZymoGenetics' cash o...

Merck, J&J arbitration on drug rights starts soon

2010-09-07T14:21:38Z

Merck: Arbitration with Johnson & Johnson over arthritis drugs' revenue to start in weeks

Drugmaker Merck & Co. says arbitration will begin in late September in its dispute with Johnson & Johnson over revenue from two blockbuster drugs for rheumatoid arthritis. The dispute arose when Merck bought Reuters) - French drugmaker Sanofi-Aventis would be prepared to moderately raise its $69 per share offer for Genzyme if the U.S. biotech agreed to negotiate, Dow Jones<...

Aqua Bounty biotech salmon OK to eat: FDA

2010-09-03T08:50:23Z

WASHINGTON (Reuters) - Aqua Bounty Technologies Inc's genetically engineered salmon are as safe to eat as normal Atlantic salmon, U.S. regulators said in a preliminary analysis released on Friday. The fish, called AquAdvantage, are genetically altered to grow twice as fast as normal ...

Special Report: Outgunned FDA tries to get tough with drug ads

2010-09-03T05:20:52Z

SILVER SPRING, Maryland (Reuters) - It wasn't what you would call a casual get-together. In February 2009, a popular New York blogger attended a brunch with fellow "frazzled moms." They took in tips from a style expert and listened to a nurse extol the virtues of

You'd have to be sick to touch this drug stock

2010-09-01T22:43:09Z

PFE has done nothing but go down

Don't people buy stocks because they think the stocks will go up in value? Well not Pfizer (NYSE: PFE) shareholders. If you're a Pfizer shareholder, maybe you need the company to develop a drug that makes you smarter, because it certainly isn't making you richer. To continue reading please click here 82456020&bid=informcom" />

Ex-hedge fund manager charged with insider trading

2010-09-01T10:45:10Z

NEW YORK (Reuters) - A former hedge fund manager has been accused by a U.S. regulator of illegal insider trading in MedImmune Inc securities prior to the acquisition of the pharmaceutical company by Britain's Reuters) - Genzyme Corp Chief Executive Henri Termeer said he is willing to sell the company he built up over 25 years, but not for $69 a share. In an interview with Reuters, Termeer said it was unlikely that French drugmaker China, court documents showed Tuesday. Huang Kexue, 45, was a researcher at Dow AgroSciences, a subsidiary of

Custom Sensors And Technology Cleaning Validation

2010-09-09T02:50:08Z

Cleaning validation procedures are an integral part of pharmaceutical manufacturing. It is of utmost importance to ensure that the process of cleaning validation is performed properly to ensure that there is no incidence of cross-contamination in the manufacturing process.

Custom Sensors and Technology, based in Fenton MO, has the equipment neces...

Sanofi-Aventis offers $18.5 billion for Genzyme

2010-08-29T10:15:09Z

French drug giant Sanofi-Aventis SA on Sunday publicly launched its $18.5 billion cash bid for American biotech firm Genzyme Corp. — a move that follows months of rumored interest and failed attempts to bring Genzyme's management to the table. Under terms of the proposed acquisition, Genzyme shareholders would receive $69 per share, representing a ...

Astra's Brilinta wins early backing in guidelines

2010-08-29T08:30:16Z

STOCKHOLM (Reuters) - AstraZeneca's new blood-thinning drug Brilinta has been given a class 1 recommendation as a treatment option under European medical guidelines, even though it has yet to be approved for sale. New

Biographical data on J&J CEO Bill Weldon

2010-08-27T14:45:08Z

NAME: William C. Weldon AGE: 61 EDUCATION: Quinnipiac University, bachelor's degree. PERSONAL: Married, two children, one grandson. PROFESSIONAL EXPERIENCE: Johnson & Johnson Chairman and CEO since April 2002. Previously served as: worldwide head of J&J's pharmaceuticals division, since 1998; chairman of Reuters) - The U.S. Food and Drug Administration has released its latest list of possible drug safety concerns, citing Roche's breast cancer drug Herceptin and Sanofi Aventis' heart drug

How Does Pharmaceutical Training Benefit Medical Businesses

2010-09-08T19:14:53Z

Pharmaceutical training is essential for medical device businesses, pharmaceutical companies and nutraceutical organisations that play a huge role in our everyday lives. They carry out an important role in providing the world's national health services with quality products that can enable them to treat patients with the very best care and medical attention.

Of course, because many of the products that pharmaceutical businesses manufacture are critical to saving th...

Bunge CFO to leave for Celgene Corp.

2010-08-26T11:45:05Z

Bunge CFO Fouse to depart Sept. 24 for Celgene Corp.

Bunge Ltd., an international agribusiness and food company, said Thursday its chief financial officer plans to leave for another company. Jacqualyn A. Fouse, 49, will depart Sept. 24 to become CFO of the Celgene Corp., a global bio...

Mass. reaches $1.35M settlement with biotech co.

2010-08-26T08:15:50Z

Mass. reaches $1.35M settlement with biotech company Stryker over product marketing

Massachusetts officials say a biotech company has agreed to pay $1.35 million to resolve allegations that it marketed medical products for purposes that had not been approved by regulators. Attorney General Martha Coakley said in a statement Thursday that Hopkinton-based St...

Novartis takes control of eye care firm Alcon

2010-08-26T03:30:13Z

Novartis completes $38.7 billion purchase of Nestle's stake in eye care firm Alcon

Swiss pharmaceutical company Novartis AG says it has completed its purchase of Nestle SA's 77 percent stake in eye care firm Alcon Inc. at a total cost of $38.7 billion. Novartis says it bought the 52 percent still owned by Nestl...

Corrected -Glaxo starts final clinical trial of shingles vaccine

2010-08-23T20:45:06Z

Corrects name of virus in 5th paragraph. LONDON (Reuters) - British pharmaceutical giant GlaxoSmithKline said on Monday it had started final trials of its new vaccine to prevent shingles, one of the most significant products in its pipeline. More than 30,000 patients worldwide will take part in the Phase III trial, Glaxo said. "Shingles is an often debil...

Scientists create smell detector using frog eggs

2010-08-23T17:15:13Z

HONG KONG (Reuters Life!) - Researchers in Japan have created a highly accurate sensor that can detect smells and gases using genetically engineered frog eggs. In a paper published in the Proceedings of the National Academy of Sciences on Tuesday, they said they hoped to use the invention to des...

Hemispherx says it was awarded $188M in lawsuit

2010-08-18T08:30:28Z

Hemispherx says court awarded it $188M in lawsuit against JCI for fraudulent takeover attempt

Hemispherx Biopharma has been awarded a $188 million judgment against a South African investment firm that tried to take over the company using false information. The damages were assessed this month by a

Biomechanics Of Golf Swing

2010-09-08T17:06:41Z

Recently I have been looking into the biomechanics of golf swing. I was not keen on looking at it to start with as just the name made me think that it would be very complicated and that I would not be able to understand it. I kept seeing it mentioned and just ignoring everything to do with it.

However, I was beginning to feel that there must be something to it, if it is mentioned so much and I really ought to take a look and at least just see whether it is something that I could ...

Shire will pull blood-pressure drug cited by FDA

2010-08-17T12:45:23Z

Shire PLC said Tuesday it will pull a blood-pressure drug off the market following warnings from federal regulators who said the drug has not been proven effective. The Irish drugmaker said in a statement it will withdraw ProAmatine by the end of September. The announcement came one day after the Food and Drug Administration threatened to pull the drug...

Summary Box: Lilly halts Alzheimer's drug

2010-08-17T11:30:14Z

Summary Box: Eli Lilly halts development of potential Alzheimer's drug in late-stage testing

DRUG DEVELOPMENT HALTED: Indianapolis drugmaker Eli Lilly and Co. said Tuesday it stopped developing the potential Alzheimer's disease treatment semagacestat when late-stage studies showed it did not slow the disease, and patients taking it fare...

FDA calls for withdrawal of drug it approved on a fast track

2010-08-16T17:15:17Z

The Food and Drug Administration said Monday the drug midodrine, which is used to treat low blood pressure, should be withdrawn from the market because no follow-up studies have been done to show it has clinical benefits. It is the first time that the FDA has taken such an action against a drug approved on a fast track basis. The agency said patients who use midodrine should stop taking it and consult...

U.S. proposes withdrawal of Shire hypotension drug

2010-08-16T11:15:06Z

WASHINGTON (Reuters) - U.S. health officials on Monday proposed withdrawing approval of a Shire Plc hypotension drug because the company failed to conduct post-approval studies. The drug, ProAmatine, was approved in 1996 to treat orthostatic hypotension, a type of low blood pressure. Generic makers of the medicine mu...

Judge's ruling uproots use of biotechnology beets

2010-08-14T09:30:16Z

Judge revokes government's approval of genetically altered sugar beets until further review

A federal judge has revoked the government's approval of genetically altered sugar beets until regulators complete a more thorough review of how the scientifically engineered crops affect organic food. Friday's ruling by U.S. District Judge Jeffrey S. White means sugar beet growers won't be able to plant the modified...

PDL BioPharma plunges on dispute with Genentech

2010-08-13T09:30:21Z

PDL Biopharma dives after Genentech disputes Europe patents of 4 drugs, including Herceptin

Shares of PDL BioPharma Inc. plunged Friday on word of a royalty dispute between PDL and its collaborator Genentech. Genentech has informed PDL that it do...

The patent ran out?? Pharmaceutical giant and then welcome the test failure

2010-09-09T11:12:15Z

The world's fourth-largest pharmaceutical company Novartis has announced its 2009 operating results. Filing shows: Novartis in 2009 net Sell Grew 11%, record company history; operating income up 11%; net income rose 4% to 8.5 billion U.S. dollars; basic earnings per share growth of 8% to 4.50 U.S. dollars, higher than 2008's 3.59 U.S. dollars, for 13 years to achieve growth of shareholder dividend. Novartis said innovation and high performance in 2009, largely thanks to the pharmaceutical sector...

Omaha man sues makers of drug Rituxan

2010-09-01T12:16:16Z

Omaha man sues Biogen, Genentech, alleging drug Rituxan made him susceptible to infection

An Omaha man who contracted an infection that rendered him a quadriplegic after taking the immunosuppressant Rituxan says the drugs makers knew of that risk but didn'...

Teva completes buyout of German drugmaker

2010-08-10T05:16:02Z

Teva closes $4.95B deal for German drugmaker Ratiopharm, broadens footprint in Europe

Teva Pharmaceutical has solidified operations further in Europe, announcing Tuesday that it completed a $4.95 billion buyout of German drugmaker Ratiopharm. Teva is the world...

Summary Box: Merck foreign sales practices probed

2010-08-09T15:00:09Z

BRIBERY PROBE: Drugmaker Merck says the Justice Department and Securities and Exchange Commission are investigating whether it broke laws against bribing officials in foreign countries to win business. FED FOCUS: The Justice Departm...

British group protests entry of cloned animals to food chain

2010-08-06T10:15:44Z

A British animal welfare group on Friday delivered a petition of 7,000 names calling on the government to prevent products from cloned animals entering the food chain. The petition, delivered by activists wearing "cloned" masks of Prime Minister David Cameron, was hastily organised after news emerged this week that meat from offspring of a cloned cow had entered the British food chain. Written by Compassion for World Farming, the ...

Protests over cloned animals in food chain

2010-08-06T06:15:34Z

An animal welfare group on Friday delivered a petition of 7,000 names calling on the government to prevent products from cloned animals entering the food chain. The petition, delivered by activists wearing "cloned" masks of Prime Minister David Cameron, was hastily organised after news emerged this week that meat from offspring of a cloned cow had entered the food chain. Written by Compassion for World Farming, the petition called...

Yunnan 37 due to a severe drought cut into three price spikes carrying water for irrigation mu

2010-09-08T15:53:30Z

Yunnan Wenshan drought concern. Nearly 97% of the 37 were produced in Yunnan Wenshan. The 37 bases of the seedlings in the Yanshan County, Wenshan Prefecture. However, because of drought, coupled with drug hoarding, the price of 37 from 70 yuan per kilogram last year rose to 440 yuan yesterday.
Carrying water for irrigation to spend 60,000 yuan mu 37
Prince Township are located in Yanshan County, east mountain is a good deal of a few acres of land on both sides of the 37 seed shed. I...

Cloned cattle investigation stirs row in Britain

2010-08-05T04:15:27Z

Britain faced fresh questions over its food standards regime on Thursday after it emerged that meat from two offspring of a cloned cow had entered the food chain. The two bulls whose meat was eaten by unwitting members of the public were among eight cattle conceived using embryos harvested from a cloned cow in the United States. It is thought there may be more than 100 de...

Cow clone may have over 100 descendants in Britain

2010-08-04T19:15:28Z

A cloned cow whose offspring's meat entered the British food chain may have more than 100 descendants in the country, records suggested Thursday, amid fears about their spread into the food system. Three cattle born from the American clone had produced 97 calves, according to details on the website of Holstein UK, the body responsible for registering all pedigree cows and bulls on farms. The news came after food safety officials admi...

Cow clone may have over 100 descendants

2010-08-04T19:15:25Z

Junior exploration stock pops on Quebec gold assays

2010-08-04T19:15:11Z

This as a biopharma play falls on FDA response to drug application

'+company+ ' (TSX: '+exchange+'.'+symbol+', Stock Forum)'+percent+'

Stockhouse Canadian Small and Micro-cap Stock Report for Wednesday, August 4th, 2010 Reuters Life!) - Britain's food watchdog said it had found that meat from the offspring of a cloned cow had entered the UK food chain and had been eaten, stirring controversy over whether such products are ethical. The Food Standards Agency (FSA) said that under European rules, suppl...

Court revives retaliation suit against Wyeth

2010-08-04T11:01:55Z

NEW YORK (Reuters) - A federal appeals court revived a retaliation lawsuit against Wyeth Pharmaceuticals Inc by a black former chemist and engineer, while dismissing his claims of racial bias. The decision issued Wednesday by the U.S. Second Circuit Court of Appeals entitles the plaint...

Rogue Farmer

2010-08-18T00:16:11Z

In this Tuesday, Aug. 10, 2010 photo Giorgio Fidenato holds a raw ear of yellow corn in his office in Pordenone, northern Italy. Fidenato's corn is genetically modified, grown in fields of surreptitiously, and, detractors say, illegally planted Monsanto seed in northeastern Italy...

Food and Farm Rogue Farmer

2010-08-18T00:16:09Z

In this Tuesday, Aug. 10, 2010 photo Giorgio Fidenato stands on on 350 square meters (almost an acre) of nearly mature corn genetically altered to resist pesticides that just a day before had been trampled by 70 anti-GMO activists, near Pordenone, northern Italy. Giorgio Fidenato's corn is genetically modified, grown in fields of surreptitiou...

Cymbalta FDA Review

2010-09-01T12:17:06Z

FILE - In this Jan. 25, 2006 file photo, a production technician at Eli Lilly and Company, examines Cymbalta 60mg pills in Indianapolis. The Food and Drug Administration has posted its review of Eli Lilly and Co.'s application to mark...

Vaccine Sales

2010-08-13T10:30:49Z

This undated product image provided by Pfizer Inc. on Friday, Aug. 13, 2010, shows the Prevnar 13 vaccine. (AP Photo/Pfizer Inc.) NO SALES.

...

Teva Pharma Ratiopharm

2010-08-10T05:45:23Z

FILE - In this photograph taken Jan. 8. 2009, a pharmacist holds a package of pain pills by Ratiopharm, a German generic medicine company, out of a shelf in Berlin. Teva Pharmaceutical has solidified operations further in Europe...

Biotech Research